Log in to save to my catalogue

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8b2a9bab2824aeb89b45d16a004e426

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

About this item

Full title

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-04, Vol.15 (1), p.12500-12, Article 12500

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

With the heterogeneous use and interpretation of next-generation molecular imaging and approval of new treatment strategies, therapeutic decision-making for
de novo
metastatic hormone-sensitive prostate cancer (mHSPC) is becoming increasingly challenging. It is conceivable that patients are treated differently in another country, hospital or...

Alternative Titles

Full title

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d8b2a9bab2824aeb89b45d16a004e426

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8b2a9bab2824aeb89b45d16a004e426

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-96065-9

How to access this item